Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (321)	8/10/2003 8:15:33 PM
From: scaram(o)uche	Respond to of 824

>> Why can not be simple and strait forward release where anyone with little efforts can come to informed conclusion? << Because that's most of the fun, telling the good guys from the bad guys. :-( Yeah, that binary event concept looks better and better, given the BS and selective disclosures. But, still, showing respect for FDA and the clinical investigators and walking that line while showing your enthusiasm to shareholders? How do you do that, when you've just missed your primary endpoint? We'll know in November if it was sincere enthusiasm or BS. I hope you're wrong. I don't follow them closely, but they've always felt like a science-first company. I don't have an opinion re. ALXN, the investment, other than to acknowledge the leverage. But I could see myself, given sincere enthusiasm, writing a PR that was something like that one. I hope you're wrong. I won't be surprised if you aren't.